Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition

By Dewanjee Saikat   K. Dua Tarun   Bhattacharjee Niloy   Das Anup   Gangopadhyay Moumita   Khanra Ritu   Joardar Swarnalata   Riaz Muhammad   De Feo Vincenzo   Zia-Ul-Haq Muhammad  

Molecules, Vol. 22, Iss. 6, 2017-05 ,pp. : 871-871

MDPI

Access to resources Recommend Favorite

Effects of HMG-CoA Reductase Inhibitors on the Pharmacokinetics of Losartan and Its Main Metabolite EXP-3174 in Rats: Possible Role of CYP3A4 and P-gp Inhibition by HMG-CoA Reductase Inhibitors

By  

Pharmacology, Vol. 88, Iss. 1-2, 2011-06 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells

By Wang Yunshan   Ma Guangxin   Wang Qin   Wen Mingxin   Xu Yangyang   He Xiuquan   Zhang Pengju   Wang Yuli   Yang Taomei   Zhan Panpan   Wei Guangwei  

Molecules, Vol. 19, Iss. 1, 2013-12 ,pp. : 159-176

MDPI

Access to resources Recommend Favorite

Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP

By Gameiro Mariline   Silva Renata   Rocha-Pereira Carolina   Carmo Helena   Carvalho Félix   Bastos Maria de Lourdes   Remião Fernando  

Molecules, Vol. 22, Iss. 4, 2017-04 ,pp. : 600-600

MDPI

Access to resources Recommend Favorite

Development of Classification Models for Identifying “True” P-glycoprotein (P-gp) Inhibitors Through Inhibition, ATPase Activation and Monolayer Efflux Assays

By Rapposelli Simona   Coi Alessio   Imbriani Marcello   Bianucci Anna Maria  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-06 ,pp. : 6924-6943

MDPI

Access to resources Recommend Favorite